Psoas Tenotomy Under Ultrasound (TEPSe)

February 8, 2024 updated by: Centre Hospitalier Universitaire de Nice

The ilio-psoas conflict is a commonly accepted complication after total hip replacement, often linked to a mispositioning of the acetabular prosthetic component that conflicts with the ilio-psoas tendon. To correct these pains, a psoas tenotomy can be proposed. The results proven by the literature are very satisfactory. Psoas tenotomy is performed endoscopically, arthroscopically, or more rarely open.

The contribution of echo surgery allows to limit the scar ransom but also to free itself from a complex infrastructure to the operating room including an arthroscopy column and an intraoperative fluoroscopy for a conventional tenotomy, This also saves procedural and installation time.

No studies to date have described ultrasound-assisted psoas tenotomy Yhe investigators conducted a cadaveric study of the feasibility of psoas tenotomy under ultrasound that confirms the feasibility of this technique and the safety of the gesture for the surrounding anatomical structures.

The objectives of this study are to assess the feasibility, pain and functional outcomes of ultrasound-assisted psoas tenotomy in patients with ilio-psoas conflict after total hip replacement.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Alpes Maritimes
      • Nice, Alpes Maritimes, France, 06000
        • Recruiting
        • Nice University Hospital
        • Contact:
        • Principal Investigator:
          • Grégoire MICICOI

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion criteria:

  • Patients 18 years of age or older
  • Indication of psoas tenotomy for ilio-psoas conflict after total hip replacement
  • Signature of the written informed consent form by the patient
  • Affiliation to a French health insurance scheme or equivalent

Non Inclusion criteria:

  • Vulnerable people: pregnant or breast-feeding women (patients will undergo a pregnancy test: urinary test), adult under guardianship or deprived of freedom.
  • Allergies to local anesthetics
  • Patient on anticoagulant or antiplatelet agents
  • Contraindication to surgery
  • Refusal of patient involvement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient with ilio-psoas conflict and having a tenotomy indication
Tenotomy of the ilio-psoas tendon under ultrasound is performed using an ultrasound machine, a 3 mm Acufex hook blade and a specific kit usually used for guided vertebroplasty and which allows the introduction of the Acufex hook blade atraumatically (foam end). The patient, under general anesthesia, is placed in supine position with the hip extending from 15 to 20°.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the success rate of this new ultrasound-guided ilio-psoas tendon tenotomy technique
Time Frame: 3 weeks post-operative
The success of this new ultrasound-guided ilio-psoas tendon tenotomy technique will be assessed by the disappearance of the ilio-psoas conflict after surgery. This criterion will be measured at the first control consultation
3 weeks post-operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the new ultrasound-guided ilio-psoas tendon tenotomy technique compared to standard practice on pain experienced by the patient
Time Frame: Pre-operative, 3 hours, 1 day, 3 weeks, 6 weeks, 3 and 6 months post-operative
The pain felt by the patient will be collected using a numerical scale from 0 to 10 before surgery, 3 hours after surgery, the day after surgery, then 3 weeks, 6 weeks, 3 months and 6 months after surgery. Zero '0', means that the patient has no pain ; '10', means that the patient has extreme pain. The non-inferiority limit is set at 1.5 on the pain EVA scale
Pre-operative, 3 hours, 1 day, 3 weeks, 6 weeks, 3 and 6 months post-operative
Evaluate the technical difficulty of surgical procedure
Time Frame: the day after surgery
The technical difficulty of surgical procedure will be assessed using a 4-point Likert scale: on the day of the operation, the surgeon will have to answer the question "What was the difficulty experienced by you in the operation?". He may answer by: Very difficult, difficult, moderately difficult or easy.
the day after surgery
Evaluate the operative time
Time Frame: the day of surgery
The operative time will be expressed in minutes between skin incision and skin closure
the day of surgery
Evaluate the installation time
Time Frame: the day of surgery
The installation time will be expressed in minutes between the end of intubation and the beginning of the brush
the day of surgery
Evaluate the total blood loss
Time Frame: in the month before surgery and the day after surgery
Total blood loss will be calculated according to the ostheo formula, including pre-operative (in the month preceding the surgery) and post-operative (the day after surgery) hematocrit values. This measure makes it possible to accurately assess the hidden blood losses related to the hematic extravasation
in the month before surgery and the day after surgery
Evaluate the length of hospital stay
Time Frame: the day after surgery
The length of hospital stay will be expressed in hours, between the entry and the discharge of the patient
the day after surgery
Evaluate the scarring after surgery
Time Frame: 6 weeks post-operative
The scarring after surgery will be evaluated at 6 weeks after surgery using a subjective scar satisfaction score (4-point Likert scale), transmitted by the patient himself. The patient will have to answer the question "Are you satisfied with your scar?". He can answer: Very satisfied, satisfied, dissatisfied or very dissatisfied.
6 weeks post-operative
Evaluate the patient satisfaction with the results of the operation
Time Frame: 3 weeks, 6 weeks, 3 and 6 months post-operative
Patient satisfaction will be assessed at 3 weeks, 6 weeks, 3 months and 6 months post-surgery using a 4-point Likert scale. To do this, the patient will have to answer the question: "Are you satisfied with the results of your surgery?". They can answer with: very satisfied, satisfied, dissatisfied, or very dissatisfied.
3 weeks, 6 weeks, 3 and 6 months post-operative
Evaluate the forgotten hip sensation
Time Frame: 3 weeks, 6 weeks, 3 and 6 months post-operative
The forgotten hip sensation will be assessed by the patient himself at 3 weeks, 6 weeks, 3 months and 6 months after surgery by answering the question "Have you forgotten your hip?". The patient can answer yes or no.
3 weeks, 6 weeks, 3 and 6 months post-operative
Evaluate the early (< 90 days) and late (> 90 days) surgical complications related to surgery
Time Frame: During 6 months after surgery
Early complications (< 90 days after surgery) and late complications (> 90 days after surgery) will be sought the day after surgery and throughout the follow-up period. They will be classified as major (infections at the surgical site or medical complications increasing the length of hospitalization) or minor according to the series of the literature
During 6 months after surgery
Evaluate the rate of patient requiring a stay in a rehabilitation center
Time Frame: During 6 months after surgery
The number of patients requiring rehabilitation will be collected for the duration of the study
During 6 months after surgery
Evaluate the Oxford Hip Score
Time Frame: At baseline, 3 weeks, 6 weeks, 3 and 6 months post-operative
The Oxford Hip Score is a questionnaire that assesses pain and hip function of patients who have undergone total hip replacement surgery. Patient should reflect on their pain and functional abilities on the previous 4 weeks. The questionnaire is divided into 2 domains (pain and function), each domain being composed of 6 questions. For each question, 5 answers are possible, each with a score of 0 to 4 (None = 4, Minimal = 3, Slight = 2, Moderate = 1, Severe = 0). The total score ranges from 0 (most severe symptoms) to 48 (no symptoms).
At baseline, 3 weeks, 6 weeks, 3 and 6 months post-operative
Evaluate the Harris Hip Score
Time Frame: At baseline, 3 weeks, 6 weeks, 3 and 6 months post-operative
The Harris Hip Score assess the results of hip surgery. It is composed of 10 questions divided into 4 domains (pain, function without deformation and amplitude of movements). A score is assigned to each response. The total score varies from 0 to 100. The higher the score, the better the results and the less dysfunctional the patient
At baseline, 3 weeks, 6 weeks, 3 and 6 months post-operative
Evaluation the Postel and Merle Aubigne score
Time Frame: At baseline, 3 weeks, 6 weeks, 3 and 6 months post-operative
the Postel and Merle Aubigne score measures pain, joint mobility and walking. For each question, 6 answers are possible, each one having a score of 0 to 6. The total score varies from 0 to 18, 18 indicating a perfect hip
At baseline, 3 weeks, 6 weeks, 3 and 6 months post-operative
Evaluate the impact of the patient's quality of life
Time Frame: At baseline, 6 weeks, 3 and 6 months post-operative
Quality of life will be evaluated using the EuroQol five-dimension questionnaire (EQ-5D-5L), at inclusion, 6 weeks, 3 and 6 months after surgery.The EQ-5D-5L comprises a descriptive system and a visual analogue scale (VAS). The descriptive system is composed of five health dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) with 5 levels of health (no problems, slight problems, moderate problems, severe problems and extreme problems). For each of the 5 dimensions, the participant's answer is converted to a number between 1 and 5, expressing the health state reported. The responses are combined to produce a five-digit number describing the participant's health status which is converted to a utility value from the country specific value set. The French EQ-5D-5L value set has utility between -0.530 (health condition worse than death) and 1 (best possible health). The VAS records the self-rated health status on a graduated scale from 0 to 100.
At baseline, 6 weeks, 3 and 6 months post-operative
Evaluate the subjective value of the hip
Time Frame: at baseline, 3 weeks, 6 weeks, 3 and 6 months post-operative
The subjective value of the hip will be assessed at inclusion, 3 weeks, 6 weeks, 3 months and 6 months after surgery by the patient himself. By answering the question "What then is the overall percentage value of your hip if a completely normal hip equals 100%?" , the patient should assess his hip on a scale of 0 to 100, 100 corresponding to a perfect hip.
at baseline, 3 weeks, 6 weeks, 3 and 6 months post-operative
Evaluate the Forgotten Hip score.
Time Frame: at baseline, 6 weeks, 3 and 6 months post-operative
The forgotten hip score will be assessed at inclusion, 6 weeks, 3 and 6 months after surgery. The score is composed of 12 questions assessing the degree of forgetfulness. For each question, the patient may respond with never, almost never, rarely, sometimes, often.
at baseline, 6 weeks, 3 and 6 months post-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2024

Primary Completion (Estimated)

March 1, 2026

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

September 26, 2023

First Submitted That Met QC Criteria

September 26, 2023

First Posted (Actual)

October 3, 2023

Study Record Updates

Last Update Posted (Actual)

February 9, 2024

Last Update Submitted That Met QC Criteria

February 8, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 22-AOIP-07

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Injuries

Clinical Trials on Psoas tenotomy under ultrasound

3
Subscribe